Qinghai Spring(SH:600381) Zheng Quan Zhi Xing·2025-07-03 16:15Core Viewpoint - The legal opinion letter confirms that the procedures for convening and holding the shareholders' meeting of Qinghai Spring Pharmaceutical Resources Technology Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][6][8]. Group 1: Meeting Procedures - The meeting was convened by the company's board of directors, with a notice published on June 17, 2025, detailing the meeting's agenda, voting methods, and logistics [2][3]. - The meeting took place on July 3, 2025, at the specified location, with the chairman authorizing a director to preside over the meeting [3][4]. Group 2: Attendance and Voting - A total of 388 shareholders attended the meeting, holding 306,670,352 shares, which represents 52.2382% of the total voting shares [6]. - The voting process combined on-site and online methods, with specific timeframes for each voting method as outlined in the notice [4][6]. Group 3: Voting Results - The resolution regarding the ratification of daily related transactions received 59,916,856 votes in favor, accounting for 1.8989% of the valid votes cast [6][8]. - The election of Mr. Wang Fugui as an independent director of the ninth board received 265,336,651 votes, indicating substantial support from the shareholders [8]. Group 4: Legal Compliance - The legal opinion concludes that all aspects of the meeting, including the convening, attendance, voting procedures, and results, are in accordance with the Company Law, Shareholders' Meeting Rules, and the company's articles of association, thus deemed valid [8][9].